WHAT IS PHARMACOGENETIC TESTING?
Pharmacogenetic testing, also called DNA Drug Sensitivity Testing, is the testing of certain genes to determine how individuals might react to specific medications. With insight derived from pharmacogenetic testing, healthcare providers may decrease the need for “trial-and-error” dosing and might substantially reduce the risk Adverse Drug Events (ADEs).
Imperial Laboratories’ Pharmacogenetic Testing provides insight into a patient’s genetic propensity to experience a drug-to-drug interaction or to be non-responsive with certain medication classes.
This information is invaluable to clinicians whether they are initiating therapy or evaluating a patient’s progress. We evaluate 49 separate genes and over 120 variants to create an easy to understand report on 15 drug classes and 182 pharmacologic agents. This provides the clinician with one of the most robust reports in the industry and will help guide the clinician’s choices in pharmacotherapy.